Ip highlights the uniform safety of patient-administered etripamil nasal spray across a series of phase 2 and 3 studies.
James Ip, MD
Advertisement
James Ip, MD, is a professor and cardiologist at Weill Cornell Medicine.
Articles by James Ip, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
SimpleScreen CRC Blood Test Meets Endpoints in Clinical Validation Study
2
Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B
3
Eplontersen Misses Primary Endpoint in Phase 3 ATTR-CM Trial
4
Biologic Therapy for Asthma and COPD: Real-World Perspectives From APPs
5